Part 5/6:
Design targeted drugs rapidly by modeling how different molecules interact with misfolded or malfunctioning proteins.
Accelerate drug discovery processes, potentially reducing the development time for new therapies from years to months.
Personalize medicine by tailoring treatments based on a patient's specific molecular makeup.
In essence, researchers can now almost instantaneously identify both the problem—how a protein might fold into a disease-causing structure—and the solution—designing a molecule that can prevent or correct that folding. This dual capability ushers in a new era where biological and medical research becomes more predictive, precise, and efficient.